GieseChad.jpg (Original)

Chad Giese


Chad is an industry leading expert helping organizations manage the present while planning for a successful future by supporting the critical junction where strategy meets execution. Building on more than 25 years of health care experience, Chad leads the development of Sg2’s service line research, advancing thought leadership across multiple service line teams to ensure members have the strategic insights and future projections to set them up for long-term growth and sustainability, while also navigating the current landscape. In addition, he brings together Sg2 and Vizient® data analytics to find novel approaches to using cost, quality and market data to provide a comprehensive view that enhances service line strategies, clinical decision-making and performance improvement. As a seasoned expert, Chad is committed to guiding organizations in making strategic decisions that leverage the entire care continuum.

Previous to joining Sg2, Chad spent 14 years in the medical device industry with Medtronic. He worked eight years in Medtronic’s cardiac rhythm disease management research department identifying novel uses for approved pacemakers and implantable cardioverter defibrillators, as well as making significant advancements in the area of 3D imaging. He also worked in the neuromodulation division for six years, managing large clinical trials that generated pivotal clinical data necessary for FDA approval of implantable devices. His work generated 22 patents, three publications and multiple internal company awards of excellence. In 2013, he was listed as one of Minnesota’s top 500 inventors by the Twin Cities Business Journal.

Chad earned an MBA from DePaul University in Illinois and a BA in biology from Middlebury College in Vermont. He understands the value of cardiovascular health from being a professional cross-country skier for nearly a decade after college. He has represented the US at World Cup competitions and was a US national champion.